F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, and A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 68 (2018) 394-424.
 J.M. Llovet, A.M. Di Bisceglie, J. Bruix, B.S. Kramer, R. Lencioni, A.X. Zhu, M. Sherman, M. Schwartz, M. Lotze, J. Talwalkar, and G.J. Gores, Design and endpoints of clinical trials in hepatocellular carcinoma. Journal of the National Cancer Institute 100 (2008) 698-711.
 P. Tabrizian, G. Jibara, B. Shrager, M. Schwartz, and S. Roayaie, Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Annals of surgery 261 (2015) 947-55.
 B.R. Nelson, C.A. Makarewich, D.M. Anderson, B.R. Winders, C.D. Troupes, F. Wu, A.L. Reese, J.R. McAnally, X. Chen, E.T. Kavalali, S.C. Cannon, S.R. Houser, R. Bassel-Duby, and E.N. Olson, A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science 351 (2016) 271-5.
 D.M. Anderson, K.M. Anderson, C.L. Chang, C.A. Makarewich, B.R. Nelson, J.R. McAnally, P. Kasaragod, J.M. Shelton, J. Liou, R. Bassel-Duby, and E.N. Olson, A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell 160 (2015) 595-606.
 A. Fatica, and I. Bozzoni, Long non-coding RNAs: new players in cell differentiation and development. Nature reviews. Genetics 15 (2014) 7-21.
 M.G. Fernandez-Barrena, M.J. Perugorria, and J.M. Banales, Novel lncRNA T-UCR as a potential downstream driver of the Wnt/beta-catenin pathway in hepatobiliary carcinogenesis. Gut 66 (2017) 1177-1178.
 W. Li, Z. Zhang, X. Liu, X. Cheng, Y. Zhang, X. Han, S. Liu, J. Yang, B. Xu, L. He, L. Sun, J. Liang, and Y. Shang, The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. The Journal of clinical investigation 127 (2017) 3421-3440.
 J.H. Xu, W.H. Chang, H.W. Fu, W.Q. Shu, T. Yuan, and P. Chen, Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC. Biochemical and biophysical research communications 490 (2017) 920-926.
 X. Zhao, Y. Liu, and S. Yu, Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Biochimica et biophysica acta. Molecular basis of disease 1863 (2017) 1805-1816.
 R. Tang, J.C. Wu, L.M. Zheng, Z.R. Li, K.L. Zhou, Z.S. Zhang, D.F. Xu, and C. Chen, Long noncoding RNA RUSC1-AS-N indicates poor prognosis and increases cell viability in hepatocellular carcinoma. European review for medical and pharmacological sciences 22 (2018) 388-396.
 Y. Wu, P.S. Wang, B.G. Wang, L. Xu, W.X. Fang, X.F. Che, X.J. Qu, Y.P. Liu, and Z. Li, Genomewide identification of a novel six-LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma. Cancer medicine 7 (2018) 6219-6233.
 J. Yan, C. Zhou, K. Guo, Q. Li, and Z. Wang, A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Journal of cellular biochemistry 120 (2019) 213-223.
 J. Gao, P.W. Kwan, and D. Shi, Sparse kernel learning with LASSO and Bayesian inference algorithm. Neural networks : the official journal of the International Neural Network Society 23 (2010) 257-64.
 K. Kourou, T.P. Exarchos, K.P. Exarchos, M.V. Karamouzis, and D.I. Fotiadis, Machine learning applications in cancer prognosis and prediction. Computational and structural biotechnology journal 13 (2015) 8-17.
 J.X. Gu, X. Zhang, R.C. Miao, X.H. Xiang, Y.N. Fu, J.Y. Zhang, C. Liu, and K. Qu, Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. World journal of gastroenterology 25 (2019) 220-232.
 A.J. Vickers, A.M. Cronin, E.B. Elkin, and M. Gonen, Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC medical informatics and decision making 8 (2008) 53.
 A.J. Vickers, B. Van Calster, and E.W. Steyerberg, Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352 (2016) i6.
 W. Huang da, B.T. Sherman, and R.A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37 (2009) 1-13.
 N. Berndt, J. Eckstein, N. Heucke, R. Gajowski, M. Stockmann, D. Meierhofer, and H.G. Holzhutter, Characterization of Lipid and Lipid Droplet Metabolism in Human HCC. Cells 8 (2019).
 J. Gu, X. Zhang, R. Miao, X. Ma, X. Xiang, Y. Fu, C. Liu, W. Niu, and K. Qu, A three-long non-coding RNA-expression-based risk score system can better predict both overall and recurrence-free survival in patients with small hepatocellular carcinoma. Aging 10 (2018) 1627-1639.
 J.H. Choi, M.J. Kim, Y.K. Park, J.Y. Im, S.M. Kwon, H.C. Kim, H.G. Woo, and H.J. Wang, Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype. Oncotarget 8 (2017) 22903-22916.
 A. Notarpaolo, R. Layese, P. Magistri, M. Gambato, M. Colledan, G. Magini, L. Miglioresi, A. Vitale, G. Vennarecci, C.D. Ambrosio, P. Burra, F. Di Benedetto, S. Fagiuoli, M. Colasanti, G. Maria Ettorre, A. Andreoli, U. Cillo, A. Laurent, S. Katsahian, E. Audureau, F. Roudot-Thoraval, and C. Duvoux, Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. Journal of hepatology 66 (2017) 552-559.
 R.H. Yuan, Y.M. Jeng, R.H. Hu, P.L. Lai, P.H. Lee, C.C. Cheng, and H.C. Hsu, Role of p53 and beta-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 15 (2011) 321-9.
 S.Y. Lee, I.T. Konstantinidis, A.A. Eaton, M. Gonen, T.P. Kingham, M.I. D'Angelica, P.J. Allen, Y. Fong, R.P. DeMatteo, and W.R. Jarnagin, Predicting recurrence patterns after resection of hepatocellular cancer. HPB : the official journal of the International Hepato Pancreato Biliary Association 16 (2014) 943-53.
 K.W. Ma, W.H. She, T.T. Cheung, A.C.Y. Chan, W.C. Dai, J.Y.Y. Fung, C.M. Lo, and K.S.H. Chok, Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy. Surgery today (2019).
 J.H. Shim, M.J. Jun, S. Han, Y.J. Lee, S.G. Lee, K.M. Kim, Y.S. Lim, and H.C. Lee, Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Annals of surgery 261 (2015) 939-46.
 S.X. Wu, J. Huang, Z.W. Liu, H.G. Chen, P. Guo, Q.Q. Cai, J.J. Zheng, H.D. Qin, Z.S. Zheng, X. Chen, R.Y. Zhang, S.L. Chen, and T.X. Lin, A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer. EBioMedicine 31 (2018) 54-65.
 Y. Liu, J. Zhu, X. Ma, S. Han, D. Xiao, Y. Jia, and Y. Wang, ceRNA network construction and comparison of gastric cancer with or without Helicobacter pylori infection. Journal of cellular physiology 234 (2019) 7128-7140.
 C. Yue, Y. Ren, H. Ge, C. Liang, Y. Xu, G. Li, and J. Wu, Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma. OncoTargets and therapy 12 (2019) 561-576.
 H.P. Xian, Z.L. Zhuo, Y.J. Sun, B. Liang, and X.T. Zhao, Circulating long non-coding RNAs HULC and ZNFX1-AS1 are potential biomarkers in patients with gastric cancer. Oncology letters 16 (2018) 4689-4698.
 C. Xu, Y. Shao, T. Xia, Y. Yang, J. Dai, L. Luo, X. Zhang, W. Sun, H. Song, B. Xiao, and J. Guo, lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 35 (2014) 9701-6.
 L. Feng, Y. Zhu, Y. Zhang, and M. Rao, LncRNA GACAT3 promotes gastric cancer progression by negatively regulating miR-497 expression. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 97 (2018) 136-142.
 B. Pan, M. Zhao, and L. Xu, Long noncoding RNA gastric cancer-associated transcript 3 plays oncogenic roles in glioma through sponging miR-3127-5p. Journal of cellular physiology 234 (2019) 8825-8833.
 H. Zhong, J. Yang, B. Zhang, X. Wang, L. Pei, L. Zhang, Z. Lin, Y. Wang, and C. Wang, LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2. Cancer biomarkers : section A of Disease markers 22 (2018) 787-797.
 W. Zhou, L. Wang, Y. Miao, and R. Xing, Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149. OncoTargets and therapy 11 (2018) 1543-1552.
 B. Zhou, W. Guo, C. Sun, B. Zhang, and F. Zheng, Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell death & disease 9 (2018) 706.
 J. Gong, X. Qi, Y. Zhang, Y. Yu, X. Lin, H. Li, and Y. Hu, Long noncoding RNA linc00462 promotes hepatocellular carcinoma progression. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 93 (2017) 40-47.